We are live on ! Find out more
MP

MSD Partners Portfolio holdings

AUM $76.8M
1-Year Est. Return 34.91%
This Fund
S&P 500
This Quarter Est. Return
-22.26%
1 Year Est. Return
-34.91%
3 Year Est. Return
+3.5%
5 Year Est. Return
-35.03%
10 Year Est. Return
+34.75%
AUM
$1.14B
AUM Growth
-$183M
Cap. Flow
+$203M
Cap. Flow %
17.69%
Top 10 Hldgs %
91.97%
Holding
43
New
6
Increased
5
Reduced
3
Closed
16

Top Buys

Rank Stock Value
1
BV icon
BrightView Holdings
BV
+$175M
2
ICD
Independence Contract Drilling, Inc.
ICD
+$70.7M
3
TCRT icon
Alaunos Therapeutics
TCRT
+$20M
4
CTACU
ChaSerg Technology Acquisition Corp. Unit
CTACU
+$9.81M
5
COTY icon
Coty
COTY
+$8.43M

Top Sells

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$40.8M
2
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
+$18.3M
3
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$13.7M
4
PCG icon
PG&E
PCG
+$11.8M
5
MU icon
Micron Technology
MU
+$4.99M

Sector Composition

Rank Sector Weight
1 Miscellaneous 44.65%
2 Industrials 14.09%
3 Technology 9.94%
4 Communication Services 7.91%
5 Energy 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBRV
26
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$73K 0.01%
200
– –
ARMP icon
27
Armata Pharmaceuticals
ARMP
$217M
$3K ﹤0.01%
1,072
– –
GDX icon
28
CALL
VanEck Gold Miners ETF
GDX
$30.7B
– –
-1,200,000
Closed -$22.2M
HALO icon
29
Halozyme
HALO
$12.5B
– –
-2,245,000
Closed -$40.8M
KRE icon
30
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.22B
– –
-400,000
Closed -$23.8M
META icon
31
CALL
Meta Platforms (Facebook)
META
$1.57T
– –
-145,000
Closed -$23.8M
META icon
32
PUT
Meta Platforms (Facebook)
META
$1.57T
– –
-100,000
Closed -$16.4M
MU icon
33
CALL
Micron Technology
MU
$1.15T
– –
-1,150,000
Closed -$52M
MU icon
34
Micron Technology
MU
$1.15T
– –
-110,250
Closed -$4.99M
OGEN icon
35
Oragenics
OGEN
$2.3M
– –
-24
Closed -$49K
PCG icon
36
CALL
PG&E
PCG
$31.5B
– –
-256,000
Closed -$11.8M
PCG icon
37
PG&E
PCG
$31.5B
– –
-256,000
Closed -$11.8M
QQQ icon
38
CALL
Invesco QQQ Trust
QQQ
$489B
– –
-1,000,000
Closed -$186M
RTX icon
39
CALL
RTX Corp
RTX
$271B
– –
-397,250
Closed -$35M
SPY icon
40
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
– –
-553,500
Closed -$161M
XLF icon
41
CALL
State Street Financial Select Sector SPDR ETF
XLF
$55.5B
– –
-3,000,000
Closed -$82.7M
XOP icon
42
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.06B
– –
-670,000
Closed -$116M
TRCO
43
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
– –
-476,411
Closed -$18.3M
1
2

Similar funds

MA
McGrath & Associates Asheville, North Carolina $76.8M AUM 22.42% 1-Year Est. Return
PWS
Pursuit Wealth Strategies Raleigh, North Carolina $76.9M AUM
QM
QVIDTVM Management The Woodlands, Texas $76.6M AUM 33.48% 1-Year Est. Return
SWM
Stapp Wealth Management Olympia, Washington $76.5M AUM 21.17% 1-Year Est. Return
BC
Bayhunt Capital Mill Valley, California $77.1M AUM
VIM
VCU Investment Management Richmond, Virginia $77.1M AUM
SPC
Square Peg Capital Surry Hills, NSW, Australia $76.2M AUM 9.17% 1-Year Est. Return
SRA
Summit Rock Advisors New York $76.1M AUM

MSD Partners's Q4 2018 Portfolio in Review

As of Q4 2018, MSD Partners held 43 positions worth $1.14B, down 14% from $1.33B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

MSD Partners deployed $203M of net new capital in Q4 2018, opening 6 new positions and adding to 5 existing holdings. Its largest new stake was BrightView Holdings: 13,630,362 shares worth $139M.

By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, down from 55% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Twenty-First Century Fox, Inc. Class B, an estimated $13.7M trimmed.

  • MSD Partners's largest Q4 2018 buy was BrightView Holdings: 13,630,362 shares worth $139M.
  • MSD Partners added most to Alaunos Therapeutics in Q4 2018, an estimated $20M increase.
  • MSD Partners's biggest Q4 2018 reduction was Twenty-First Century Fox, Inc. Class B, cutting an estimated $13.7M.
  • MSD Partners fully exited Halozyme in Q4 2018, selling an estimated $40.8M.
  • MSD Partners's ten largest holdings make up 92% of its $1.14B portfolio in Q4 2018.
  • MSD Partners opened 6 new positions and closed 16 in Q4 2018.
  • MSD Partners's portfolio value fell 14% quarter-over-quarter to $1.14B.

Based on MSD Partners's 13F filing for Q4 2018, filed 14 Feb 2019.